CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 44,250 shares at $5.16 ($228,388)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 10,500 shares at $5.06 ($53,179)
- 4 Planned sale Director sold 5,000 shares at $5.06 ($25,309)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Medical Officer sold 8,040 shares at $4.80 ($38,582)
- 4 Open-market sale President and Head of R&D sold 13,206 shares at $4.80 ($63,373)
Page 10 of 32 · 631 filings